Find Faculty

Felix Richter, MD, PhD

img_Felix Richter
ADJUNCT ASSISTANT PROFESSOR | Artificial Intelligence and Human Health
Research Topics
Alzheimer's Disease, Bioinformatics, Biostatistics, Cardiovascular, Computational Biology, DNA Replication, Genetics, Genomics, Pediatrics, Personalized Medicine, RNA
Multi-Disciplinary Training Area
Artificial Intelligence and Emerging Technologies in Medicine [AIET], Genetics and Genomic Sciences [GGS], Neuroscience [NEU]

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Richter during 2025 and/or 2026. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)

  • ArtemisAI Labs

Founder/Co-Founder/Partner

  • ArtemisAI Labs

Outside Employment

  • Children's Hospital of Philadelphia

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.